| ESRRA | estrogen-related receptor alpha | 11q12
| 5.793 |
| TRMT112 | tRNA methyltransferase 11-2 homolog (S. cerevisiae) | 11q13.1
| 5.728 |
| PRDX5 | peroxiredoxin 5 | 11q13
| 5.728 |
| TEX40 | testis expressed 40 | 11q13.1
| 5.601 |
| PCDHA8 | protocadherin alpha 8 | 5q31
| 5.557 |
| PCDHA7 | protocadherin alpha 7 | 5q31
| 5.491 |
| PCDHA6 | protocadherin alpha 6 | 5q31
| 5.468 |
| PCDHA9 | protocadherin alpha 9 | 5q31
| 5.395 |
| PCDHA10 | protocadherin alpha 10 | 5q31
| 5.334 |
| SPTBN4 | spectrin, beta, non-erythrocytic 4 | 19q13.13
| 5.302 |
| IGF2 | insulin-like growth factor 2 | 11p15.5
| 5.255 |
| PCDHA5 | protocadherin alpha 5 | 5q31
| 5.183 |
| PCDHA4 | protocadherin alpha 4 | 5q31
| 5.122 |
| WNT1 | wingless-type MMTV integration site family, member 1 | 12q13.12
| 5.093 |
| TNFRSF25 | tumor necrosis factor receptor superfamily, member 25 | 1p36.2
| 5.04 |
| PCDHA11 | protocadherin alpha 11 | 5q31
| 5.026 |
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 19q13.3
| 5.01 |
| LOC100996693 | NA | NA
| 5.004 |
| PCDHA3 | protocadherin alpha 3 | 5q31
| 5.001 |
| GMPPA | GDP-mannose pyrophosphorylase A | 2q36.1
| 4.98 |
| KCNK4 | potassium channel, two pore domain subfamily K, member 4 | 11q13
| 4.939 |
| MIR7155 | microRNA 7155 | 11
| 4.887 |
| CCDC88B | coiled-coil domain containing 88B | 11q13.1
| 4.88 |
| WNT10B | wingless-type MMTV integration site family, member 10B | 12q13
| 4.864 |
| CSH2 | chorionic somatomammotropin hormone 2 | 17q22-q24
| 4.853 |
| ASIC4 | acid sensing (proton gated) ion channel family member 4 | 2q36.1
| 4.85 |
| GPR137 | G protein-coupled receptor 137 | 11q13.1
| 4.846 |
| JUND | jun D proto-oncogene | 19p13.2
| 4.84 |
| MIR3188 | microRNA 3188 | 19
| 4.832 |
| PCDHA12 | protocadherin alpha 12 | 5q31
| 4.814 |
| GALK1 | galactokinase 1 | 17q25.1
| 4.773 |
| IGF2-AS | IGF2 antisense RNA | 11p15.5
| 4.767 |
| GPR3 | G protein-coupled receptor 3 | 1p36.1-p35
| 4.767 |
| METRN | meteorin, glial cell differentiation regulator | 16p13.3
| 4.767 |
| EFNA4 | ephrin-A4 | 1q21-q22
| 4.758 |
| FAM173A | family with sequence similarity 173, member A | 16p13.3
| 4.758 |
| LOC100505666 | NA | NA
| 4.745 |
| BAD | BCL2-associated agonist of cell death | 11q13.1
| 4.742 |
| LOC102724450 | NA | NA
| 4.74 |
| RTN2 | reticulon 2 | 19q13.2-q13.3
| 4.737 |
| RNF207 | ring finger protein 207 | 1p36.31
| 4.731 |
| HSP90AB1 | heat shock protein 90kDa alpha (cytosolic), class B member 1 | 6p12
| 4.73 |
| LSM4 | LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated | 19p13.1
| 4.717 |
| GH2 | growth hormone 2 | 17q22-q24
| 4.706 |
| SYT7 | synaptotagmin VII | 11q12.2
| 4.702 |
| CROCC | ciliary rootlet coiled-coil, rootletin | 1p36.13
| 4.69 |
| HAPLN2 | hyaluronan and proteoglycan link protein 2 | 1q23.1
| 4.688 |
| FOXH1 | forkhead box H1 | 8q24.3
| 4.684 |
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) | 16q22.1
| 4.675 |
| KIAA0895L | KIAA0895-like | 16q22.1
| 4.674 |
| KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 | 10q24.32
| 4.647 |
| PCDHGB1 | protocadherin gamma subfamily B, 1 | 5q31
| 4.643 |
| NBL1 | neuroblastoma 1, DAN family BMP antagonist | 1p36.3-p36.2
| 4.634 |
| SAMD1 | sterile alpha motif domain containing 1 | 19p13.13
| 4.634 |
| PCDHB9 | protocadherin beta 9 | 5q31
| 4.631 |
| ANKRD63 | ankyrin repeat domain 63 | 15q15.1
| 4.624 |
| ELMO3 | engulfment and cell motility 3 | 16q22.1
| 4.621 |
| INS | insulin | 11p15.5
| 4.618 |
| INS-IGF2 | INS-IGF2 readthrough | 11p15.5
| 4.618 |
| HTR6 | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled | 1p36-p35
| 4.618 |
| PCDHGA3 | protocadherin gamma subfamily A, 3 | 5q31
| 4.613 |
| PDZD7 | PDZ domain containing 7 | 10q24.32
| 4.607 |
| SFXN3 | sideroflexin 3 | 10q24.32
| 4.607 |
| CDK9 | cyclin-dependent kinase 9 | 9q34.1
| 4.596 |
| KIAA1683 | KIAA1683 | 19p13.1
| 4.593 |
| MIR2861 | microRNA 2861 | 9
| 4.592 |
| MIR3960 | microRNA 3960 | 9
| 4.589 |
| PCDHGA4 | protocadherin gamma subfamily A, 4 | 5q31
| 4.58 |
| KIFC2 | kinesin family member C2 | 8q24.3
| 4.575 |
| PCDHA2 | protocadherin alpha 2 | 5q31
| 4.56 |
| PCDHB16 | protocadherin beta 16 | 5q31
| 4.56 |
| PCDHGA10 | protocadherin gamma subfamily A, 10 | 5q31
| 4.558 |
| PCDHGB6 | protocadherin gamma subfamily B, 6 | 5q31
| 4.547 |
| MFSD3 | major facilitator superfamily domain containing 3 | 8q24.3
| 4.544 |
| CYHR1 | cysteine/histidine-rich 1 | 8q24
| 4.525 |
| EXOC3L1 | exocyst complex component 3-like 1 | 16q22.1
| 4.516 |
| TRG-AS1 | T cell receptor gamma locus antisense RNA 1 | 7p14.1
| 4.507 |
| PCDHGB7 | protocadherin gamma subfamily B, 7 | 5q31
| 4.503 |
| EFNA3 | ephrin-A3 | 1q21-q22
| 4.5 |
| E2F4 | E2F transcription factor 4, p107/p130-binding | 16q22.1
| 4.497 |
| CCDC78 | coiled-coil domain containing 78 | 16p13.3
| 4.497 |
| CBX4 | chromobox homolog 4 | 17q25.3
| 4.496 |
| PPM1N | protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) | 19q13.32
| 4.494 |
| PCDHB10 | protocadherin beta 10 | 5q31.3
| 4.493 |
| MIR4647 | microRNA 4647 | 6
| 4.492 |
| SLC29A1 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 | 6p21.1
| 4.49 |
| PCDHGA9 | protocadherin gamma subfamily A, 9 | 5q31
| 4.488 |
| MEGF8 | multiple EGF-like-domains 8 | 19q13.2
| 4.485 |
| HAGHL | hydroxyacylglutathione hydrolase-like | 16p13.3
| 4.485 |
| LRRC24 | leucine rich repeat containing 24 | 8q24.3
| 4.482 |
| HIC1 | hypermethylated in cancer 1 | 17p13.3
| 4.48 |
| VPS18 | vacuolar protein sorting 18 homolog (S. cerevisiae) | 15q14-q15
| 4.475 |
| TMEM145 | transmembrane protein 145 | 19q13.2
| 4.474 |
| PPP1R16A | protein phosphatase 1, regulatory subunit 16A | 8q24.3
| 4.469 |
| DUSP7 | dual specificity phosphatase 7 | 3p21
| 4.466 |
| LOC101927272 | NA | NA
| 4.464 |
| PCDHGB2 | protocadherin gamma subfamily B, 2 | 5q31
| 4.454 |
| C19orf67 | chromosome 19 open reading frame 67 | 19p13.12
| 4.453 |
| LRRC14 | leucine rich repeat containing 14 | 8q24.3
| 4.45 |
| RECQL4 | RecQ helicase-like 4 | 8q24.3
| 4.447 |
| MIR1199 | microRNA 1199 | 19
| 4.444 |
| MYO15B | myosin XVB | 17q25.1
| 4.442 |
| MIDN | midnolin | 19p13.3
| 4.437 |
| FLT3LG | fms-related tyrosine kinase 3 ligand | 19q13.3
| 4.43 |
| ATP8B3 | ATPase, aminophospholipid transporter, class I, type 8B, member 3 | 19p13.3
| 4.43 |
| LOC113230 | NA | NA
| 4.428 |
| MIR328 | microRNA 328 | 16q22.1
| 4.417 |
| C17orf82 | chromosome 17 open reading frame 82 | 17q23.2
| 4.406 |
| MIR4252 | microRNA 4252 | 1
| 4.401 |
| TBC1D10B | TBC1 domain family, member 10B | 16p11.2
| 4.392 |
| SLC35B2 | solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2 | 6p21.1
| 4.391 |
| GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 8q24.3
| 4.389 |
| PCDHGA11 | protocadherin gamma subfamily A, 11 | 5q31
| 4.385 |
| PCDHB8 | protocadherin beta 8 | 5q31
| 4.381 |
| TCAM1P | testicular cell adhesion molecule 1, pseudogene | 17q23.3
| 4.375 |
| C8orf82 | chromosome 8 open reading frame 82 | 8q24
| 4.374 |
| ATP5D | ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit | 19p13.3
| 4.373 |
| CDKN1C | cyclin-dependent kinase inhibitor 1C (p57, Kip2) | 11p15.5
| 4.373 |
| PCDHGB5 | protocadherin gamma subfamily B, 5 | 5q31
| 4.373 |
| PPOX | protoporphyrinogen oxidase | 1q22
| 4.37 |
| PCDHGA2 | protocadherin gamma subfamily A, 2 | 5q31
| 4.358 |
| TBX10 | T-box 10 | 11q13.2
| 4.346 |
| MIR212 | microRNA 212 | 17p13.3
| 4.345 |
| MIR132 | microRNA 132 | 17p13.3
| 4.336 |
| B4GALT3 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 | 1q23.3
| 4.329 |
| ADAM15 | ADAM metallopeptidase domain 15 | 1q21.3
| 4.329 |
| OVCA2 | ovarian tumor suppressor candidate 2 | 17p13.3
| 4.325 |
| RPL22 | ribosomal protein L22 | 1p36.31
| 4.321 |
| PLCB3 | phospholipase C, beta 3 (phosphatidylinositol-specific) | 11q13
| 4.317 |
| CYB561 | cytochrome b561 | 17q23.3
| 4.303 |
| RPS21 | ribosomal protein S21 | 20q13.3
| 4.292 |
| MYLPF | myosin light chain, phosphorylatable, fast skeletal muscle | 16p11.2
| 4.292 |
| PCDHGA5 | protocadherin gamma subfamily A, 5 | 5q31
| 4.291 |
| ZNF48 | zinc finger protein 48 | 16p11.2
| 4.279 |
| PNCK | pregnancy up-regulated nonubiquitous CaM kinase | Xq28
| 4.27 |
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 3p21.31
| 4.269 |
| PCDHGB3 | protocadherin gamma subfamily B, 3 | 5q31
| 4.263 |
| PCDHB11 | protocadherin beta 11 | 5q31
| 4.258 |
| ZYX | zyxin | 7q32
| 4.257 |
| MIR6892 | microRNA 6892 | 7
| 4.253 |
| ATP6V1B1-AS1 | ATP6V1B1 antisense RNA 1 | 2p13.3
| 4.243 |
| C19orf26 | NA | NA
| 4.242 |
| MIR483 | microRNA 483 | 11p15.5
| 4.234 |
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 19p13.1
| 4.233 |
| AHDC1 | AT hook, DNA binding motif, containing 1 | 1p36.13
| 4.232 |
| CABLES2 | Cdk5 and Abl enzyme substrate 2 | 20q13.33
| 4.225 |
| REXO1 | REX1, RNA exonuclease 1 homolog | 19p13.3
| 4.219 |
| PCDHA13 | protocadherin alpha 13 | 5q31
| 4.218 |
| ZNF511 | zinc finger protein 511 | 10q26.3
| 4.218 |
| MIR1909 | microRNA 1909 | 19p13.3
| 4.217 |
| CD164L2 | CD164 sialomucin-like 2 | 1p36.11
| 4.21 |
| PNPLA5 | patatin-like phospholipase domain containing 5 | 22q13.31
| 4.208 |
| TUBGCP2 | tubulin, gamma complex associated protein 2 | 10q26.3
| 4.205 |
| NUDT8 | nudix (nucleoside diphosphate linked moiety X)-type motif 8 | 11q13.2
| 4.194 |
| HSF4 | heat shock transcription factor 4 | 16q21
| 4.186 |
| ANKRD53 | ankyrin repeat domain 53 | 2p13.3
| 4.184 |
| PTMA | prothymosin, alpha | 2q37.1
| 4.184 |
| PPP1R14B | protein phosphatase 1, regulatory (inhibitor) subunit 14B | 11q13
| 4.182 |
| PCDHGA6 | protocadherin gamma subfamily A, 6 | 5q31
| 4.178 |
| FZR1 | fizzy/cell division cycle 20 related 1 | 19p13.3
| 4.168 |
| CORO6 | coronin 6 | 17q11.2
| 4.163 |
| PCDHGA8 | protocadherin gamma subfamily A, 8 | 5q31
| 4.159 |
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter), member 8 | Xq28
| 4.159 |
| ESPN | espin | 1p36.31
| 4.156 |
| C10orf91 | chromosome 10 open reading frame 91 | 10q26.3
| 4.149 |
| MIR5787 | microRNA 5787 | 3
| 4.148 |
| NARFL | nuclear prelamin A recognition factor-like | 16p13.3
| 4.144 |
| FBXL16 | F-box and leucine-rich repeat protein 16 | 16p13.3
| 4.144 |
| PCDHGB4 | protocadherin gamma subfamily B, 4 | 5q31
| 4.142 |
| LOC101927495 | NA | NA
| 4.138 |
| KCNH2 | potassium channel, voltage gated eag related subfamily H, member 2 | 7q36.1
| 4.133 |
| INAFM2 | InaF-motif containing 2 | 15q15.1
| 4.132 |
| DUSP9 | dual specificity phosphatase 9 | Xq28
| 4.126 |
| PCDHGB8P | protocadherin gamma subfamily B, 8 pseudogene | 5q31.3
| 4.119 |
| SH2D3C | SH2 domain containing 3C | 9q33.1-q33.3
| 4.114 |
| LHB | luteinizing hormone beta polypeptide | 19q13.3
| 4.113 |
| TH | tyrosine hydroxylase | 11p15.5
| 4.112 |
| FBXL8 | F-box and leucine-rich repeat protein 8 | 16q22.1-q22.3
| 4.11 |
| PLCB2 | phospholipase C, beta 2 | 15q15.1
| 4.107 |
| TRADD | TNFRSF1A-associated via death domain | 16q22
| 4.106 |
| LOC101059948 | NA | NA
| 4.104 |
| H3F3B | H3 histone, family 3B (H3.3B) | 17q25.1
| 4.1 |
| SSBP4 | single stranded DNA binding protein 4 | 19p13.1
| 4.099 |
| LINC00482 | long intergenic non-protein coding RNA 482 | 17q25.3
| 4.094 |
| C19orf71 | chromosome 19 open reading frame 71 | 19p13.3
| 4.075 |
| JMJD8 | jumonji domain containing 8 | 16p13.3
| 4.075 |
| MIR4686 | microRNA 4686 | 11
| 4.072 |
| ACY3 | aminoacylase 3 | 11q13.2
| 4.067 |
| SMIM5 | small integral membrane protein 5 | 17q25.1
| 4.064 |
| C9orf69 | chromosome 9 open reading frame 69 | 9q34.3
| 4.064 |
| CHD5 | chromodomain helicase DNA binding protein 5 | 1p36.3
| 4.053 |
| PCDHGA7 | protocadherin gamma subfamily A, 7 | 5q31
| 4.052 |
| HES5 | hes family bHLH transcription factor 5 | 1p36
| 4.051 |
| PCDHB12 | protocadherin beta 12 | 5q31
| 4.048 |
| PLEKHG5 | pleckstrin homology domain containing, family G (with RhoGef domain) member 5 | 1p36.31
| 4.048 |
| LGR6 | leucine-rich repeat containing G protein-coupled receptor 6 | 1q32.1
| 4.046 |
| PCDHB7 | protocadherin beta 7 | 5q31
| 4.044 |
| CYB561D1 | cytochrome b561 family, member D1 | 1p13.2
| 4.044 |
| KCNAB2 | potassium channel, voltage gated subfamily A regulatory beta subunit 2 | 1p36.3
| 4.042 |
| CFD | complement factor D (adipsin) | 19p13.3
| 4.033 |